![Andriy Mushak](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Andriy Mushak
Finanzdirektor/CFO bei
TELOMIR PHARMACEUTICALS, INC.
Profil
Andriy Mushak began working as Chief Financial Officer at Telomir Pharmaceuticals, Inc. in 2026 and continues in this role.
In the same year, Mr. Mushak also started as Chief Financial Officer at MIRA Pharmaceuticals, Inc. and remains in this position.
Aktive Positionen von Andriy Mushak
| Unternehmen | Position | Beginn |
|---|---|---|
| TELOMIR PHARMACEUTICALS, INC. | Finanzdirektor/CFO | 06.06.2026 |
| MIRA PHARMACEUTICALS, INC. | Finanzdirektor/CFO | 06.06.2026 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
1
Beziehungen ersten Grades
2
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
MIRA Pharmaceuticals, Inc.
 MIRA Pharmaceuticals, Inc. Pharmaceuticals: OtherHealth Technology Develops and sells new molecular synthetic THC for the treatment of adult patients with anxiety and cognitive decline | Health Technology |
Telomir Pharmaceuticals, Inc.
 Telomir Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops a novel small molecule as the first regulator of telomere length and genomic stability | Health Technology |
